Michael Allen
Concepts (262)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Psychomotor Agitation | 25 | 2017 | 71 | 4.460 |
Why?
| Antipsychotic Agents | 23 | 2017 | 193 | 4.010 |
Why?
| Suicidal Ideation | 14 | 2023 | 400 | 2.730 |
Why?
| Suicide, Attempted | 22 | 2023 | 316 | 2.690 |
Why?
| Bipolar Disorder | 24 | 2012 | 209 | 2.640 |
Why?
| Emergency Services, Psychiatric | 15 | 2019 | 36 | 2.580 |
Why?
| Psychotic Disorders | 11 | 2016 | 135 | 1.730 |
Why?
| Emergency Service, Hospital | 17 | 2021 | 1865 | 1.640 |
Why?
| Schizophrenia | 8 | 2017 | 501 | 1.530 |
Why?
| Suicide | 20 | 2023 | 500 | 1.310 |
Why?
| Mass Screening | 15 | 2023 | 1052 | 1.250 |
Why?
| Benzodiazepines | 9 | 2016 | 122 | 1.200 |
Why?
| Restraint, Physical | 6 | 2016 | 94 | 1.150 |
Why?
| Mental Disorders | 10 | 2017 | 939 | 0.960 |
Why?
| Aggression | 4 | 2016 | 183 | 0.940 |
Why?
| Haloperidol | 5 | 2016 | 36 | 0.890 |
Why?
| Risk Management | 3 | 2019 | 90 | 0.870 |
Why?
| Antimanic Agents | 5 | 2009 | 15 | 0.870 |
Why?
| Psychological Tests | 2 | 2017 | 129 | 0.790 |
Why?
| Promethazine | 3 | 2016 | 4 | 0.770 |
Why?
| Emergency Medical Services | 6 | 2016 | 589 | 0.740 |
Why?
| Telephone | 2 | 2019 | 152 | 0.700 |
Why?
| Professional-Patient Relations | 1 | 2019 | 147 | 0.640 |
Why?
| Psychiatric Status Rating Scales | 14 | 2016 | 499 | 0.630 |
Why?
| Loxapine | 3 | 2012 | 4 | 0.620 |
Why?
| Lurasidone Hydrochloride | 1 | 2017 | 1 | 0.610 |
Why?
| Program Development | 1 | 2019 | 357 | 0.600 |
Why?
| Medical History Taking | 2 | 2017 | 120 | 0.600 |
Why?
| Risk Assessment | 11 | 2019 | 3057 | 0.570 |
Why?
| Injections, Intramuscular | 7 | 2008 | 116 | 0.560 |
Why?
| Physical Examination | 2 | 2017 | 243 | 0.550 |
Why?
| Emergency Medicine | 2 | 2017 | 238 | 0.530 |
Why?
| Anticonvulsants | 2 | 2009 | 184 | 0.500 |
Why?
| Adult | 43 | 2021 | 31512 | 0.500 |
Why?
| Depressive Disorder, Major | 3 | 2008 | 303 | 0.480 |
Why?
| Humans | 82 | 2023 | 118974 | 0.480 |
Why?
| Communication | 1 | 2019 | 761 | 0.470 |
Why?
| Evidence-Based Medicine | 2 | 2009 | 693 | 0.450 |
Why?
| Depression | 4 | 2023 | 1132 | 0.450 |
Why?
| Lithium Carbonate | 2 | 2009 | 6 | 0.450 |
Why?
| Self-Injurious Behavior | 4 | 2021 | 120 | 0.440 |
Why?
| Dibenzothiazepines | 2 | 2009 | 20 | 0.440 |
Why?
| Substance-Related Disorders | 6 | 2008 | 971 | 0.420 |
Why?
| Acute Disease | 9 | 2017 | 940 | 0.420 |
Why?
| Middle Aged | 29 | 2021 | 27617 | 0.410 |
Why?
| Valproic Acid | 3 | 2006 | 44 | 0.400 |
Why?
| Observation | 3 | 2009 | 50 | 0.380 |
Why?
| Male | 41 | 2021 | 57801 | 0.360 |
Why?
| Tranquilizing Agents | 2 | 2008 | 2 | 0.360 |
Why?
| Violence | 3 | 2011 | 218 | 0.340 |
Why?
| Female | 41 | 2021 | 61565 | 0.340 |
Why?
| Nicotine | 1 | 2011 | 276 | 0.320 |
Why?
| Prospective Studies | 13 | 2023 | 6471 | 0.320 |
Why?
| Smoking | 3 | 2011 | 1487 | 0.310 |
Why?
| Comorbidity | 8 | 2019 | 1527 | 0.310 |
Why?
| Double-Blind Method | 6 | 2017 | 1687 | 0.300 |
Why?
| Risk Factors | 13 | 2023 | 9000 | 0.300 |
Why?
| Borderline Personality Disorder | 1 | 2007 | 13 | 0.300 |
Why?
| Informed Consent | 1 | 2008 | 163 | 0.300 |
Why?
| Primary Health Care | 6 | 2023 | 1560 | 0.290 |
Why?
| Disease Management | 2 | 2016 | 571 | 0.290 |
Why?
| International Cooperation | 1 | 2007 | 177 | 0.290 |
Why?
| Drug Therapy, Combination | 5 | 2016 | 965 | 0.290 |
Why?
| Psychometrics | 4 | 2015 | 631 | 0.280 |
Why?
| Academic Medical Centers | 2 | 2011 | 422 | 0.280 |
Why?
| Guidelines as Topic | 1 | 2007 | 262 | 0.270 |
Why?
| Alcoholism | 2 | 2015 | 717 | 0.260 |
Why?
| Advisory Committees | 3 | 2017 | 212 | 0.250 |
Why?
| Hypnotics and Sedatives | 1 | 2005 | 136 | 0.250 |
Why?
| Midazolam | 3 | 2016 | 49 | 0.250 |
Why?
| Piperazines | 4 | 2007 | 316 | 0.240 |
Why?
| Motivation | 2 | 2006 | 506 | 0.240 |
Why?
| United States | 16 | 2021 | 12555 | 0.240 |
Why?
| Young Adult | 9 | 2021 | 10793 | 0.230 |
Why?
| Adolescent | 15 | 2021 | 18480 | 0.220 |
Why?
| Quality of Health Care | 1 | 2007 | 586 | 0.220 |
Why?
| Activities of Daily Living | 1 | 2005 | 354 | 0.210 |
Why?
| Pilot Projects | 2 | 2019 | 1419 | 0.210 |
Why?
| Thiazoles | 3 | 2007 | 121 | 0.210 |
Why?
| Cost-Benefit Analysis | 3 | 2022 | 554 | 0.200 |
Why?
| Patient Satisfaction | 1 | 2005 | 610 | 0.190 |
Why?
| Randomized Controlled Trials as Topic | 4 | 2016 | 1244 | 0.180 |
Why?
| Preventive Psychiatry | 1 | 2019 | 7 | 0.180 |
Why?
| Aged | 11 | 2019 | 19657 | 0.180 |
Why?
| Quetiapine Fumarate | 2 | 2009 | 25 | 0.170 |
Why?
| Schizophrenic Psychology | 2 | 2011 | 113 | 0.170 |
Why?
| Lorazepam | 2 | 2016 | 24 | 0.170 |
Why?
| Cognition Disorders | 1 | 2003 | 529 | 0.160 |
Why?
| Health Services Research | 2 | 2013 | 385 | 0.160 |
Why?
| Quality of Life | 2 | 2008 | 2366 | 0.160 |
Why?
| Consensus | 2 | 2017 | 534 | 0.150 |
Why?
| Diagnostic and Statistical Manual of Mental Disorders | 3 | 2008 | 239 | 0.150 |
Why?
| Hospitalization | 4 | 2021 | 1785 | 0.150 |
Why?
| Utilization Review | 2 | 2008 | 36 | 0.150 |
Why?
| Risperidone | 2 | 2007 | 27 | 0.150 |
Why?
| Treatment Outcome | 8 | 2012 | 9342 | 0.150 |
Why?
| Drug Administration Schedule | 2 | 2011 | 736 | 0.150 |
Why?
| Severity of Illness Index | 7 | 2008 | 2674 | 0.140 |
Why?
| Surveys and Questionnaires | 6 | 2021 | 4708 | 0.140 |
Why?
| Combined Modality Therapy | 4 | 2017 | 1166 | 0.140 |
Why?
| Longitudinal Studies | 6 | 2011 | 2513 | 0.140 |
Why?
| Antidepressive Agents, Second-Generation | 2 | 2007 | 37 | 0.140 |
Why?
| Referral and Consultation | 2 | 2019 | 648 | 0.140 |
Why?
| Antidepressive Agents | 3 | 2008 | 189 | 0.140 |
Why?
| Altitude Sickness | 1 | 2017 | 163 | 0.140 |
Why?
| Quinolones | 2 | 2007 | 98 | 0.140 |
Why?
| Patient Admission | 2 | 2008 | 176 | 0.140 |
Why?
| Aftercare | 1 | 2017 | 194 | 0.140 |
Why?
| Administration, Inhalation | 3 | 2012 | 656 | 0.130 |
Why?
| Multicenter Studies as Topic | 3 | 2019 | 253 | 0.130 |
Why?
| Patient Discharge | 1 | 2021 | 796 | 0.130 |
Why?
| Dose-Response Relationship, Drug | 3 | 2011 | 1945 | 0.130 |
Why?
| Cognition | 1 | 2022 | 1024 | 0.130 |
Why?
| Decision Support Techniques | 1 | 2018 | 364 | 0.130 |
Why?
| Aged, 80 and over | 5 | 2017 | 6561 | 0.120 |
Why?
| Reproducibility of Results | 3 | 2015 | 2874 | 0.120 |
Why?
| Drug Administration Routes | 1 | 2013 | 42 | 0.120 |
Why?
| Crisis Intervention | 2 | 2019 | 25 | 0.120 |
Why?
| Altitude | 1 | 2017 | 422 | 0.120 |
Why?
| Age of Onset | 5 | 2008 | 467 | 0.110 |
Why?
| Caregivers | 2 | 2009 | 709 | 0.100 |
Why?
| Military Personnel | 1 | 2019 | 529 | 0.100 |
Why?
| Patient Safety | 1 | 2015 | 281 | 0.100 |
Why?
| Safety | 3 | 2009 | 304 | 0.100 |
Why?
| Hospitals, General | 2 | 2009 | 19 | 0.100 |
Why?
| Transdermal Patch | 1 | 2011 | 14 | 0.100 |
Why?
| Psychiatric Department, Hospital | 1 | 2011 | 18 | 0.100 |
Why?
| Chronic Disease | 1 | 2017 | 1636 | 0.100 |
Why?
| Administration, Oral | 3 | 2008 | 756 | 0.100 |
Why?
| Aripiprazole | 2 | 2007 | 18 | 0.100 |
Why?
| Genetic Predisposition to Disease | 2 | 2010 | 2275 | 0.100 |
Why?
| Emergencies | 2 | 2010 | 153 | 0.090 |
Why?
| National Institutes of Health (U.S.) | 1 | 2010 | 115 | 0.090 |
Why?
| Affect | 2 | 2009 | 240 | 0.090 |
Why?
| Aerosols | 1 | 2011 | 221 | 0.090 |
Why?
| Family Health | 2 | 2009 | 201 | 0.090 |
Why?
| Circadian Rhythm Signaling Peptides and Proteins | 1 | 2009 | 2 | 0.090 |
Why?
| Placebos | 2 | 2011 | 202 | 0.090 |
Why?
| Chromosomes, Human, Pair 6 | 1 | 2010 | 47 | 0.090 |
Why?
| Mental Health | 2 | 2013 | 568 | 0.090 |
Why?
| Colorado | 1 | 2019 | 4196 | 0.090 |
Why?
| Health Personnel | 2 | 2007 | 588 | 0.090 |
Why?
| Interview, Psychological | 1 | 2009 | 93 | 0.090 |
Why?
| Long-Term Care | 1 | 2009 | 74 | 0.090 |
Why?
| Psychiatry | 2 | 2016 | 201 | 0.090 |
Why?
| Diagnosis, Dual (Psychiatry) | 2 | 2006 | 36 | 0.090 |
Why?
| Linkage Disequilibrium | 1 | 2010 | 273 | 0.090 |
Why?
| Health Status | 2 | 2019 | 726 | 0.080 |
Why?
| Internship and Residency | 2 | 2009 | 1001 | 0.080 |
Why?
| Personality Assessment | 2 | 2006 | 78 | 0.080 |
Why?
| Prevalence | 2 | 2013 | 2326 | 0.080 |
Why?
| Hospitals, Psychiatric | 1 | 2008 | 19 | 0.080 |
Why?
| Recreation | 1 | 2008 | 26 | 0.080 |
Why?
| Age Factors | 4 | 2019 | 2995 | 0.080 |
Why?
| Demography | 2 | 2006 | 274 | 0.080 |
Why?
| Brazil | 1 | 2008 | 109 | 0.080 |
Why?
| Depressive Disorder | 3 | 2008 | 333 | 0.080 |
Why?
| Follow-Up Studies | 6 | 2017 | 4596 | 0.080 |
Why?
| Nervous System Diseases | 1 | 2010 | 261 | 0.080 |
Why?
| Paroxetine | 1 | 2007 | 7 | 0.080 |
Why?
| Treatment Refusal | 1 | 2008 | 86 | 0.080 |
Why?
| Conscious Sedation | 1 | 2008 | 79 | 0.070 |
Why?
| Bupropion | 1 | 2007 | 38 | 0.070 |
Why?
| Smoking Cessation | 1 | 2011 | 360 | 0.070 |
Why?
| Switzerland | 1 | 2006 | 27 | 0.070 |
Why?
| Quality Assurance, Health Care | 1 | 2009 | 325 | 0.070 |
Why?
| Personal Satisfaction | 1 | 2008 | 188 | 0.070 |
Why?
| Narcotics | 1 | 2007 | 50 | 0.070 |
Why?
| Europe | 1 | 2007 | 356 | 0.070 |
Why?
| Diagnosis, Differential | 2 | 2008 | 1384 | 0.070 |
Why?
| Fluphenazine | 1 | 2006 | 5 | 0.070 |
Why?
| Alcohol-Related Disorders | 1 | 2007 | 111 | 0.070 |
Why?
| Bayes Theorem | 1 | 2008 | 344 | 0.070 |
Why?
| Health Services Misuse | 1 | 2006 | 36 | 0.070 |
Why?
| Time Factors | 4 | 2011 | 6412 | 0.070 |
Why?
| Lithium | 1 | 2005 | 41 | 0.070 |
Why?
| Interrupted Time Series Analysis | 2 | 2015 | 45 | 0.070 |
Why?
| Recurrence | 2 | 2007 | 975 | 0.070 |
Why?
| Curriculum | 2 | 2012 | 910 | 0.060 |
Why?
| Polymorphism, Single Nucleotide | 2 | 2010 | 2062 | 0.060 |
Why?
| Cocaine-Related Disorders | 1 | 2006 | 107 | 0.060 |
Why?
| Personality Inventory | 1 | 2005 | 134 | 0.060 |
Why?
| Serotonin Plasma Membrane Transport Proteins | 1 | 2005 | 73 | 0.060 |
Why?
| Biomedical Research | 1 | 2010 | 612 | 0.060 |
Why?
| Practice Guidelines as Topic | 2 | 2016 | 1440 | 0.060 |
Why?
| Dangerous Behavior | 1 | 2004 | 20 | 0.060 |
Why?
| Statistics as Topic | 1 | 2005 | 307 | 0.060 |
Why?
| Urban Health Services | 1 | 2004 | 60 | 0.060 |
Why?
| Incidence | 2 | 2011 | 2424 | 0.060 |
Why?
| Marijuana Abuse | 1 | 2006 | 209 | 0.060 |
Why?
| Linear Models | 1 | 2006 | 827 | 0.060 |
Why?
| Sex Factors | 3 | 2019 | 1781 | 0.060 |
Why?
| Serotonin | 1 | 2005 | 309 | 0.050 |
Why?
| Analysis of Variance | 1 | 2006 | 1293 | 0.050 |
Why?
| Cross-Sectional Studies | 3 | 2008 | 4552 | 0.050 |
Why?
| Kaplan-Meier Estimate | 2 | 2017 | 842 | 0.050 |
Why?
| Anxiety Disorders | 1 | 2005 | 309 | 0.050 |
Why?
| Secondary Prevention | 2 | 2017 | 227 | 0.050 |
Why?
| Polymorphism, Genetic | 1 | 2005 | 642 | 0.050 |
Why?
| Geriatric Assessment | 1 | 2003 | 185 | 0.050 |
Why?
| Length of Stay | 1 | 2006 | 1032 | 0.050 |
Why?
| Disclosure | 1 | 2019 | 102 | 0.040 |
Why?
| Health Status Indicators | 1 | 2019 | 154 | 0.040 |
Why?
| Inservice Training | 1 | 2019 | 106 | 0.040 |
Why?
| Postcards as Topic | 1 | 2017 | 1 | 0.040 |
Why?
| DNA | 1 | 2005 | 1388 | 0.040 |
Why?
| Rhode Island | 1 | 2017 | 23 | 0.040 |
Why?
| Hotlines | 1 | 2017 | 25 | 0.040 |
Why?
| Substance Abuse Detection | 2 | 2009 | 63 | 0.040 |
Why?
| Case Management | 1 | 2017 | 63 | 0.040 |
Why?
| Attitude of Health Personnel | 1 | 2004 | 992 | 0.040 |
Why?
| Algorithms | 2 | 2019 | 1541 | 0.040 |
Why?
| Cohort Studies | 4 | 2008 | 5116 | 0.030 |
Why?
| Child | 3 | 2021 | 19129 | 0.030 |
Why?
| Disease Progression | 1 | 2003 | 2490 | 0.030 |
Why?
| Socioeconomic Factors | 1 | 2019 | 1129 | 0.030 |
Why?
| Psychotherapy | 1 | 2017 | 177 | 0.030 |
Why?
| Meta-Analysis as Topic | 1 | 2016 | 164 | 0.030 |
Why?
| Research Design | 2 | 2013 | 969 | 0.030 |
Why?
| Outpatients | 1 | 2017 | 325 | 0.030 |
Why?
| Logistic Models | 2 | 2012 | 1901 | 0.030 |
Why?
| Educational Status | 1 | 2015 | 437 | 0.030 |
Why?
| Models, Statistical | 1 | 2017 | 636 | 0.030 |
Why?
| Feasibility Studies | 1 | 2015 | 749 | 0.030 |
Why?
| Societies | 1 | 2012 | 42 | 0.030 |
Why?
| Animals | 1 | 2013 | 33381 | 0.030 |
Why?
| Case-Control Studies | 2 | 2010 | 3171 | 0.030 |
Why?
| Professional Competence | 1 | 2012 | 91 | 0.030 |
Why?
| Mental Status Schedule | 1 | 2009 | 38 | 0.020 |
Why?
| Health Care Surveys | 1 | 2011 | 546 | 0.020 |
Why?
| Continuity of Patient Care | 1 | 2011 | 265 | 0.020 |
Why?
| Checklist | 1 | 2009 | 81 | 0.020 |
Why?
| International Classification of Diseases | 1 | 2009 | 122 | 0.020 |
Why?
| Cyclothymic Disorder | 1 | 2008 | 3 | 0.020 |
Why?
| Chromosome Mapping | 1 | 2010 | 510 | 0.020 |
Why?
| Chi-Square Distribution | 1 | 2009 | 525 | 0.020 |
Why?
| Gene Frequency | 1 | 2009 | 513 | 0.020 |
Why?
| Databases, Genetic | 1 | 2009 | 253 | 0.020 |
Why?
| Self Concept | 1 | 2009 | 215 | 0.020 |
Why?
| Drug Delivery Systems | 1 | 2011 | 306 | 0.020 |
Why?
| Reference Values | 1 | 2009 | 774 | 0.020 |
Why?
| Dyskinesia, Drug-Induced | 1 | 2007 | 11 | 0.020 |
Why?
| Retrospective Studies | 3 | 2009 | 12978 | 0.020 |
Why?
| Documentation | 1 | 2009 | 175 | 0.020 |
Why?
| Triage | 1 | 2009 | 203 | 0.020 |
Why?
| Cooperative Behavior | 1 | 2009 | 408 | 0.020 |
Why?
| Quality Indicators, Health Care | 1 | 2009 | 295 | 0.020 |
Why?
| Circadian Rhythm | 1 | 2009 | 401 | 0.020 |
Why?
| Models, Psychological | 1 | 2008 | 298 | 0.020 |
Why?
| Brain Injuries | 1 | 2010 | 484 | 0.020 |
Why?
| Patient Care Planning | 1 | 2005 | 143 | 0.020 |
Why?
| Predictive Value of Tests | 1 | 2009 | 1868 | 0.020 |
Why?
| Genotype | 1 | 2009 | 1882 | 0.020 |
Why?
| Drug Interactions | 1 | 2004 | 352 | 0.010 |
Why?
| Genome-Wide Association Study | 1 | 2009 | 1323 | 0.010 |
Why?
| Forecasting | 1 | 2004 | 353 | 0.010 |
Why?
| Drug Overdose | 1 | 2007 | 294 | 0.010 |
Why?
| Alcohol Drinking | 1 | 2007 | 652 | 0.010 |
Why?
| Phenotype | 1 | 2010 | 3003 | 0.010 |
Why?
| Critical Care | 1 | 2005 | 492 | 0.010 |
Why?
| Research | 1 | 2004 | 411 | 0.010 |
Why?
| Pregnancy | 1 | 2010 | 5691 | 0.010 |
Why?
|
|
Allen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|